NCT00186823 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00186823/arm-group/c4ca4238a0b923820dcc509a6f75849b]
TBI, systemic chemotherapy and antibodies as follows: [clinicaltrials_resource:a785440c777fd5d8e2818152f9fa1e2c]Stem Cell Transplantation [clinicaltrials_resource:b8e592b0f07ae730df59e6883fdec503]Miltenyi Biotec CliniMACS [clinicaltrials_resource:c870ec0c9ccc26e138cac8913514ea87]Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies [clinicaltrials:NCT00186823]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00186823 arm group c4ca4238a0b923820dcc509a6f75849b [clinicaltrials_resource:NCT00186823/arm-group/c4ca4238a0b923820dcc509a6f75849b]
Bio2RDF identifier
NCT00186823/arm-group/c4ca4238a0b923820dcc509a6f75849b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ca4238a0b923820dcc509a6f75849b
identifier
clinicaltrials_resource:NCT00186823/arm-group/c4ca4238a0b923820dcc509a6f75849b
title
NCT00186823 arm group c4ca4238a0b923820dcc509a6f75849b
@en
type
label
NCT00186823 arm group c4ca4238 ...... a4238a0b923820dcc509a6f75849b]
@en